Ming Y Lim: Demonstrating the Value of Upfront Emicizumab at ISTH 2026
Ming Y Lim, Clinical Associate Professor at the University of Utah, shared on LinkedIn:
”What makes ISTH special is the people.
Every meeting is an opportunity to connect with colleagues across disciplines, exchange ideas, learn from one another, and build collaborations that ultimately improve outcomes for patients around the world.
At ISTH 2026 in Paris, I had the privilege of presenting at the SSC Factor VIII, Factor IX, and Rare Coagulation Disorders Subcommittee led by Susan Shapiro, met with the Dengue Infection in Congenital Bleeding Disorders Working Group led by Nongnuch-Nong Sirachainan, and presenting a poster on the cost-effectiveness of upfront emicizumab use in hospitalized patients with acquired hemophilia A.
Judging by the photo, I was clearly having fun engaging with colleagues who stopped by the poster and shared their insights and questions!
Spoiler alert: Adding upfront emicizumab to standard of care was both more effective and less costly, even at current emicizumab pricing.
So grateful for the opportunity to learn from and collaborate with so many outstanding colleagues, and proud to be part of the ISTH community.”
Stay updated with Hemostasis Today.
-
Jul 22, 2026, 10:35Ifeanyichukwu Ifechidere: We’ve Trained an Entire Generation of Clinicians to Fear The Wrong Thing About HIT
-
Jul 22, 2026, 10:16Ney Carter Borges: Understanding Pathophysiology as the Foundation of Precision Cardiovascular Care
-
Jul 22, 2026, 10:01George Cieutat: Strengthening Connections Across the Bleeding Disorders Community
-
Jul 22, 2026, 09:52Danny Hsu: Get to Do Some Fun Stuff at ISTH 2026
-
Jul 22, 2026, 09:48Nita Radhakrishnan: The People Behind the Science at ISTH 2026
-
Jul 22, 2026, 09:46Clinical Trial Recruitment for the HARP Mother–Baby Study – HARP
-
Jul 22, 2026, 09:41Shaymaa Alhabib: From My First PhD Poster to ISTH 2026
-
Jul 22, 2026, 09:35A Novel Peptide Strategy to Prevent Surface-Triggered Thrombosis – JTH
-
Jul 22, 2026, 09:29Alessandra Bosch: Presenting the Latest Evidence in Pediatric Anticoagulation at ISTH 2026